Almanack Investment Partners’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Almanack Investment Partners's MDT Position: Q4 2022 in Review
Almanack Investment Partners sold out of Medtronic (MDT) in Q4 2022, closing a stake of 3,390 shares — an estimated $274K sold.
Almanack Investment Partners first reported a position in MDT in Q2 2017 and held it in 21 quarters. The position peaked at $731K in Q4 2020. 1,961 funds tracked by Wall St. Rank hold MDT as of Q4 2022.
- Almanack Investment Partners reported no remaining Medtronic position as of Q4 2022 after selling out during the quarter.
- Almanack Investment Partners sold 3,390 Medtronic shares in Q4 2022, an estimated $274K.
- Almanack Investment Partners first reported a position in Medtronic in Q2 2017 and held it in 21 quarters.
- Almanack Investment Partners's Medtronic position peaked at $731K in Q4 2020.
- 1,961 funds tracked by Wall St. Rank held Medtronic as of Q4 2022.
Based on Almanack Investment Partners's 13F filing for Q4 2022, filed 9 Feb 2023.